Publication | Closed Access
Tumor inhibitors. XXXI. Vernolepin, a novel elemanolide dilactone tumor inhibitor from Vernonia hymenolepis
115
Citations
0
References
1968
Year
Pharmaceutical ScienceAltmetric Attention ScorePharmacotherapyPharmaceutical ChemistryVernonia HymenolepisTranslational PharmacologyMolecular PharmacologyMedicinal ChemistryAnti-cancer AgentCancer ResearchMedicineSocial Media PresenceDrug DevelopmentPharmacologyBiomolecular EngineeringDonut IconTumor InhibitorsOncologyDrug Discovery
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTTumor inhibitors. XXXI. Vernolepin, a novel elemanolide dilactone tumor inhibitor from Vernonia hymenolepisS. Morris Kupchan, Richard J. Hemingway, Dieter Werner, A. Karim, A. T. McPhail, and G. A. SimCite this: J. Am. Chem. Soc. 1968, 90, 13, 3596–3597Publication Date (Print):June 1, 1968Publication History Published online1 May 2002Published inissue 1 June 1968https://pubs.acs.org/doi/10.1021/ja01015a073https://doi.org/10.1021/ja01015a073research-articleACS PublicationsRequest reuse permissionsArticle Views237Altmetric-Citations100LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts